证券代码：688619 证券简称：罗普特 公告编号：2025-024 罗普特科技集团股份有限公司 第三届董事会第三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、 董事会会议召开情况 罗普特科技集团股份有限公司（以下称"公司"）第三届董事会第三次会 议于 2025 年 6 月 6 日以现场结合通讯方式召开。本次会议通知及相关材料以电 子邮件送达公司全体董事，全体董事一致同意豁免本次董事会提前三日发出会 议通知的时间期限。本次董事会应到董事 9 人，实到董事 9 人，会议由公司董 事长陈延行先生主持。本次会议参与表决人数及召集、召开程序符合《公司 法》和《公司章程》的有关规定，会议形成的决议合法、有效。 二、董事会会议审议情况 （一）审议通过《关于取消监事会、修订 <公司章程> 及办理工商变更登记 的议案》 根据《中华人民共和国公司法》（以下简称"《公司法》"）《上市公司 章程指引》等有关规定，公司决定不再设置监事会，监事会的职权由董事会审 计委员会行使。《罗普特科技集团股份有限公司监事会议事规则》等监事会相 ...

Group 1 - The board of directors of Liaoning Times Wan Heng Co., Ltd. held its 30th meeting of the 8th session on June 6, 2025, via communication methods, with all 7 directors present, meeting legal and statutory requirements [1] - The board approved the nomination of 4 non-independent director candidates for the 9th board, proposed by the controlling shareholder, which requires shareholder meeting approval using a cumulative voting system [1] - The board also approved the nomination of 3 independent director candidates for the 9th board, which also requires shareholder meeting approval using a cumulative voting system [2] Group 2 - The board agreed to amend the company's articles of association and related rules, with certain amendments requiring shareholder meeting approval before taking effect [2] - The voting results for all proposals were unanimous, with 7 votes in favor and no votes against or abstentions [1][2]

Group 1 - The company held its 15th meeting of the second board of directors on June 6, 2025, with all 10 directors present, ensuring compliance with legal and regulatory requirements [1] - The board approved the proposal for additional expected daily related transactions for 2025, which will be submitted to the second extraordinary general meeting of shareholders for review [2][3] - The board also approved the achievement of the vesting conditions for the second vesting period of the 2022 restricted stock incentive plan, allowing 120 eligible participants to vest a total of 1.09884 million shares [3][5] Group 2 - The board approved the proposal to void a total of 0.96591 million shares of restricted stock that were granted but not vested due to performance criteria not being met [6] - The board passed a resolution to amend the company's articles of association to enhance decision-making efficiency, which will also be submitted to the extraordinary general meeting of shareholders for special resolution [7] - The board approved the establishment of a remuneration management system for directors and senior management, which will be reviewed at the upcoming extraordinary general meeting of shareholders [8] Group 3 - The board approved amendments to the independent director system and the accountant selection system, which will also be presented at the extraordinary general meeting of shareholders for review [9] - The company plans to hold the second extraordinary general meeting of shareholders on June 23, 2025, at 14:30 [9][12]

浙江健盛集团股份有限公司 章 程 二零二五年六月 目 录 第一章 总则 第一条 为维护浙江健盛集团股份有限公司（以下简称"公司"或"本公司"）、 股东、职工和债权人的合法权益，规范公司的组织和行为，根据《中华人民共和 国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下简 称"《证券法》"）和其他有关规定，制订本章程。 第二条 公司系依照《公司法》和其他有关规定成立的股份有限公司。 公司由浙江健盛袜业有限公司整体变更发起设立，在浙江省市场监督管理局 注册登记，取得营业执照，营业执照号码：91330000741008835U。 第三条 公司于 2015 年 1 月 5 日经中国证券监督管理委员会（以下简称"中 国证监会"）核准，首次向社会公众发行人民币普通股 2,000 万股，并于 2015 年 第四条 公司注册名称： 中文全称：浙江健盛集团股份有限公司 英文全称：ZHEJIANG JASAN HOLDING GROUP Co., Ltd. 集团名称：浙江健盛集团 第五条 公司住所：杭州市萧山经济技术开发区桥南区块知行路 1699 号 3 幢； 邮政编码：311210。 第六条 公司注册资本为人 ...

Group 1 - The company plans to apply for a multi-address business license, change its business scope, and relocate its registered address from "111 Jin Yi Road, Xiaoshan Economic Development Zone, Hangzhou" to "Building 3, 1699 Zhixing Road, Qiaonan Block, Xiaoshan Economic and Technological Development Zone, Hangzhou" [1][2] - The company will revise its articles of association to reflect the changes in registered address and business scope, including the removal of the supervisory board and the delegation of its powers to the audit committee of the board of directors [2][3] - The revised articles of association will include new sections on independent directors and specialized committees, clarifying their roles and responsibilities [2][3] Group 2 - The company's business scope will now include textile sales, import and export of goods, manufacturing of sports goods and equipment, and investment activities with its own funds [1][5] - The company will no longer have a supervisory board, and the audit committee will assume the supervisory functions as per the Company Law [2][3] - The company will ensure that all changes comply with relevant laws and regulations, and the final content will be subject to approval by the business registration authority [2][3]

Group 1 - The company held its eighth meeting of the third supervisory board on June 6, 2025, with all three supervisors present, complying with relevant laws and regulations [1] - The supervisory board approved a proposal to change the registered capital and amend the company's articles of association, in accordance with the latest legal requirements [1] - The company plans to distribute a cash dividend of 1.50 yuan per share, totaling 12,368,453.40 yuan, while retaining the remaining undistributed profits for the next fiscal year [2] Group 2 - The proposal for capital increase through capital reserves involves a transfer of shares to all shareholders at a ratio of 1 for every 10 shares held, with no bonus shares being issued [2] - The voting results for the proposal showed unanimous support, with 3 votes in favor and no votes against or abstentions [2] - The proposal will be submitted for review at the company's third extraordinary general meeting in 2025 [2]

| 上 | 海 | 復 | 星 | 醫 | 藥（ | 集 | 團 | ）股 | 份 | 有 | 限 | 公 | 司 | 章程 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 註 | ： | 在 | 章 | 程 | 正 | 文 | 及 | 條 | 款 | 旁 | 註 | 中 | ： | 中 | 國 | 指 | 中 | 華 | 人 | 民 | 共 | 和 ...

证券代码：600196 股票简称：复星医药 编号：临 2025-100 上海复星医药（集团）股份有限公司 第九届董事会第八十一次会议（临时会议）决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 上海复星医药（集团）股份有限公司（以下简称"本公司"或"公司"）第九 届董事会第八十一次会议（临时会议）于2025年6月6日召开，全体董事以通讯方式 出席了会议，本次会议的召开符合《中华人民共和国公司法》（以下简称"《公司 法》"）、其他有关法律法规和《上海复星医药（集团）股份有限公司章程》（以 下简称"《公司章程》"）的规定。会议审议并达成如下决议： 审议通过关于修订《公司章程》的议案。 根据本公司第九届董事会第七十六次会议、第九届监事会 2025 年第二次会议分 别审议通过的关于回购注销部分未解除限售的 A 股限制性股票的议案，截至 2025 年 股股票激励计划》项下共计 897,140 股 A 股限制性股票的回购及注销。于该等股份 回购注销完成后，本公司总股本由 2,671,326,465 股减少至 2,670,429,3 ...

Core Points - The company held its 19th meeting of the 7th Board of Directors on June 6, 2025, in Changsha, Hunan Province, with 8 out of 9 directors present [1][2] - The meeting approved several proposals, including amendments to the company's articles of association and rules for shareholder meetings, all with unanimous support [1][2] - The company plans to hold its 2024 annual shareholders' meeting on June 26, 2025, combining on-site and online voting methods [2] Summary by Categories Company Governance - The board meeting resulted in the approval of amendments to the company's articles of association, which will be submitted for review at the 2024 annual shareholders' meeting [1][2] - The meeting also approved revisions to the rules governing shareholder meetings and board meetings, with all proposals receiving unanimous votes [1][2] Upcoming Events - The company has scheduled its 2024 annual shareholders' meeting for June 26, 2025, at its headquarters, with a combination of on-site and online voting [2]

Group 1 - The company held its 37th meeting of the 10th Board of Directors on June 5, 2025, via telecommunication voting, with all nine board members present [1] - The meeting was chaired by Chairman Yang Yang and complied with the relevant provisions of the Company Law and the Articles of Association, making it valid [1] - A resolution was passed with 9 votes in favor, 0 against, 0 abstentions, and 0 evaded votes to amend the Articles of Association and its subsidiary systems [1] Group 2 - The proposal requires approval from the shareholders' meeting, needing more than two-thirds of the voting rights held by attending shareholders (including proxies) to pass [2] - Upon approval, the company will no longer have a supervisory board or supervisors, and the Audit Committee of the Board will assume the powers of the supervisory board as stipulated by the Company Law [2] - The corresponding rules for the supervisory board will be abolished, and all supervisors will complete their terms and resign [2]